Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Total Non-Current Liabilities (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Total Non-Current Liabilities for 4 consecutive years, with $144992.0 as the latest value for Q3 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 1.96% to $144992.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $144992.0, a 1.96% decrease, with the full-year FY2024 number at $147119.0, down 2.08% from a year prior.
  • Total Non-Current Liabilities was $144992.0 for Q3 2025 at 60 Degrees Pharmaceuticals, roughly flat from $145477.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $19.9 million in Q1 2023 to a low of $144992.0 in Q3 2025.
  • A 4-year average of $2.0 million and a median of $149065.0 in 2024 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: crashed 99.25% in 2024, then dropped 1.96% in 2025.
  • 60 Degrees Pharmaceuticals' Total Non-Current Liabilities stood at $1.5 million in 2022, then plummeted by 90.15% to $150251.0 in 2023, then fell by 2.08% to $147119.0 in 2024, then fell by 1.45% to $144992.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Total Non-Current Liabilities are $144992.0 (Q3 2025), $145477.0 (Q2 2025), and $146502.0 (Q1 2025).